Intellia Therapeutics (NTLA) Net Equity Issued and Repurchased (2015 - 2026)
Intellia Therapeutics (NTLA) posted Net Equity Issued and Repurchased of -$1.03 billion for Q2 2026, compared with $1.24 million a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Intellia Therapeutics was $128.46 million, down 26.6% year-over-year; for FY2025, it came in at $128.18 million, down 27.5% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 61.8% (FY2020 to FY2025).
- In prior years, Intellia Therapeutics' Net Equity Issued and Repurchased was $176.9 million in FY2024 (+47.7%), $119.8 million in FY2023 (+725.2%), $14.52 million in FY2022 (-64.7%) and $41.09 million in FY2021 (+255.1%).
- The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased in data going back to Q1 2015.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with an average decline of 5.7%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2023, with growth of 392.1%; the weakest was Q1 2023, with a decline of 91.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Intellia Therapeutics | 1.69 Bn | 1.69 Bn | - | -32.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.08 Mn |
| Mar 31, 2026 | 33.60 Mn |
| Dec 31, 2025 | 126.94 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Dec 31, 2024 | 172.07 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 114.19 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 755,000.00 |
| Dec 31, 2022 | 533,000.00 |
| Sep 30, 2022 | 722,000.00 |
| Jun 30, 2022 | 4.83 Mn |
| Mar 31, 2022 | 8.44 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | -5.39 Mn |
| Mar 31, 2021 | 45.26 Mn |
| Dec 31, 2020 | 9.61 Mn |
API Access
Intellia Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();